OR WAIT null SECS
January 17, 2008
Novo Nordisk Drops Inhaled Insulin Product, Neurocrine Appoints CEO and President, More...
January 10, 2008
Pfizer and Hikal signed a contract manufacturing agreement in which Hikal will supply active pharmaceutical ingredients.
Crucell and Sanofi Pasteur Sign Agreement, WuXi Pharma Names COO, More...
Merck & Co. and Pfizer signed separate pacts for preclinical drug candidates to treat schizophrenia.
January 09, 2008
Richard Spoor, senior vice-president of global procurement at Merck & Co., Inc., discusses the company's strategy and progress made in its supply strategy that involves increased outsourcing and implementing lean-manufacturing principles in its manufacturing network. Pharmaceutical Technology's senior editor Patricia Van Arnum moderates.
January 04, 2008
Merck Sells Facility to Cherokee Pharmaceuticals, Inflazyme Announces Senior Management Resignations, More...
January 02, 2008
The authors propose extending initial solvent screening for a single-solvent system to the cocktail solvent screening of binary and ternary solvent mixtures.
Researchers and process chemists share approaches in synthesis of active ingredients and pharmaceutical intermediates.
Brief pharmaceutical news items for January 2008.
Natural gums and mucilage are biocompatible, cheap, readily available, and represent a potential source of excipients. The authors examine the functionality of mucilage extracted from the leaves of Hibiscus rosa-sinensis Linn as an excipient in a sustained-release tablet formulation.